Assessing the Efficacy and Safety of Three Different Regimens of Etanercept (ETN) 50mg Twice a Week, Combination of ETN 25mg and Acitretin, and Acitretin Alone in Korean Psoriasis Patients.

Trial Profile

Assessing the Efficacy and Safety of Three Different Regimens of Etanercept (ETN) 50mg Twice a Week, Combination of ETN 25mg and Acitretin, and Acitretin Alone in Korean Psoriasis Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Apr 2012

At a glance

  • Drugs Acitretin; Etanercept
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 13 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 31 Aug 2010 Planned end date changed from 1 Oct 2010 to 1 Jun 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top